Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Signal transduction of eNOS activation
The FDA-approved branded product (Vyleesi) is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder in pre-menopausal women
Bottom Line: The standard protocol (0.25mg 3 days, then 0.5mg 710 days) represents the optimal risk-to-benefit ratio for most research applications
Step 2: Comprehensive Hormonal Evaluation Measuring hormone levels can help confirm suspicions of perimenopause, along with drawing connections between specific patterns in hormonal imbalances and the patient's symptomology
US$ 27.23
US$ 26.31
US$ 29.10
US$ 22.15
US$ 24.09
US$ 23.64
US$ 25.43
US$ 21.60
US$ 23.31
